Related Experiment Video
Updated: Jun 23, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glycemic control and implant stabilization in type 2 diabetes mellitus
T W Oates1, S Dowell, M Robinson
1Department of Periodontics, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA. oates@uthscsa.edu
Poor glycemic control in diabetes mellitus impairs dental implant stability. Higher HbA1c levels in diabetic patients correlate with reduced implant healing and longer recovery times, affecting osseointegration.
Area of Science:
- Oral Implantology
- Endocrinology
- Biomaterials Science
Background:
- Diabetes mellitus is often a contraindication for dental implant therapy.
- The impact of glycemic control on implant osseointegration in diabetic patients is not fully understood.
Purpose of the Study:
- To investigate the relationship between glycemic control and short-term dental implant stability in patients with type 2 diabetes.
- To test the hypothesis that poor glycemic control negatively affects implant stabilization.
Main Methods:
- Prospective clinical study involving 30 non-diabetic individuals (12 implants) and 20 individuals with type 2 diabetes (30 implants).
- Glycated hemoglobin (HbA1c) levels were measured, ranging from 4.7-12.6%.
- Implant stability was assessed using resonance frequency analysis over a 4-month period post-placement.
Main Results:
- All implants exhibited minimum stability 2-6 weeks post-placement.
- Patients with HbA1c levels of 8.1% or higher showed a greater decrease in stability and longer healing times.
- Altered implant stability was observed in relation to hyperglycemic conditions in diabetic patients.
Conclusions:
- Poor glycemic control in type 2 diabetes mellitus is associated with impaired short-term dental implant stability.
- Hyperglycemic conditions directly impact implant integration, potentially affecting long-term success.
- This research highlights the importance of glycemic management for successful dental implant outcomes in diabetic patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...